United States Antimony Co. (NYSE:UAMY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $8.75.
A number of equities research analysts have commented on the company. HC Wainwright reduced their target price on United States Antimony from $9.25 to $6.50 and set a “buy” rating on the stock in a research report on Friday. Wall Street Zen upgraded United States Antimony from a “strong sell” rating to a “sell” rating in a report on Saturday. Weiss Ratings reissued a “sell (d-)” rating on shares of United States Antimony in a research report on Monday, September 14th. Finally, Texas Capital raised United States Antimony to a “strong-buy” rating in a research report on Wednesday, October 7th.
Read Our Latest Report on United States Antimony
Insider Buying and Selling at United States Antimony
In related news, Director Joseph A. Carrabba acquired 21,300 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The shares were purchased at an average cost of $4.72 per share, for a total transaction of $100,536.00. Following the acquisition, the director owned 198,401 shares in the company, valued at $936,452.72. The trade was a 12.03% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary C. Evans acquired 20,000 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were bought at an average cost of $4.92 per share, with a total value of $98,400.00. Following the transaction, the chief executive officer directly owned 2,590,028 shares in the company, valued at $12,742,937.76. This trade represents a 0.78% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 62,700 shares of company stock valued at $298,592 over the last 90 days. 5.50% of the stock is owned by insiders.
Institutional Investors Weigh In On United States Antimony
Institutional investors and hedge funds have recently modified their holdings of the company. KBC Group NV purchased a new stake in United States Antimony during the first quarter worth about $31,000. Farther Finance Advisors LLC boosted its stake in shares of United States Antimony by 65.2% in the third quarter. Farther Finance Advisors LLC now owns 8,545 shares of the company’s stock valued at $36,000 after purchasing an additional 3,372 shares during the period. Axxcess Wealth Management LLC acquired a new position in shares of United States Antimony in the third quarter valued at approximately $44,000. Inscription Capital LLC acquired a new position in shares of United States Antimony in the third quarter valued at approximately $47,000. Finally, Wealthfront Advisers LLC acquired a new position in shares of United States Antimony in the second quarter valued at approximately $85,000. Hedge funds and other institutional investors own 9.49% of the company’s stock.
United States Antimony Trading Down 13.8%
NYSE:UAMY opened at $2.67 on Friday. The company’s 50-day moving average price is $3.72 and its 200-day moving average price is $6.86. The company has a market cap of $398.87 million, a P/E ratio of -17.77 and a beta of 0.49. United States Antimony has a twelve month low of $2.53 and a twelve month high of $12.64.
United States Antimony (NYSE:UAMY – Get Free Report) last posted its quarterly earnings results on Thursday, November 12th. The company reported ($0.06) EPS for the quarter. United States Antimony had a negative net margin of 55.44% and a negative return on equity of 7.73%. The company had revenue of $10.13 million during the quarter. On average, analysts expect that United States Antimony will post -0.01 earnings per share for the current year.
About United States Antimony
United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.
See Also
- Five stocks we like better than United States Antimony
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for United States Antimony Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United States Antimony and related companies with MarketBeat.com's FREE daily email newsletter.
